Polycystic ovarian syndrome and its potential association with bipolar disorder in patients with eating disorder

Abstract

Exploration of polycystic ovarian syndrome (PCOS) in women with eating disorders (ED) is uncommon, and its association with bipolar disorder (BD) has been understudied. The aim of this study was to determine the prevalence of PCOS in women with ED in an outpatient program and to analyze the potential associations with BD. A total of 388 patients (88 with PCOS and 300 without PCOS) aged among 14 to 61 years were included in the study. Pelvic ultrasound, laboratory tests, and physical exams were performed to each participant. Bivariate analyses were carried out between PCOS, BD and other variables such as: psychiatric comorbidities, body mass index and type of ED. An association model was built. PCOS and BD prevalence were 22.7% and 13.1% respectively. The variables associated with PCOS were: BD type II, overweight or obesity and having an ED with binges and/or purges. When obesity and bulimic ED subtypes were controlled, patients with PCOS and BD type have 5.8 times higher risk of BD type II (OR = 5.85; 95% IC = 2.9-11.6). Comorbidities among these three pathologies are frequent, therefore its exploration and management should be considered.

Manejo del síndrome de ovario poliquístico

“…Por lo tanto, deberán ser valoradas y tener un adecuado control para esta condición (7). Por último, se debe evaluar a las pacientes con este síndrome por psicopatologías, debido a que tienen mayor riesgo de presentar depresión, trastorno bipolar, ansiedad, trastornos del comportamiento alimentario como bulimia nerviosa, todo lo cual podría alterar el patrón del sueño y afectar la calidad de vida de estas mujeres y generar un impacto negativo (1).…”

“…Su alta prevalencia en edad reproductiva, se considera la endocrinopatía femenina más común. La prevalencia exacta depende de los criterios que se utilicen para establecer el diagnóstico definitivo (1), sin embargo se estima de forma general que afecta aproximadamente entre el 5% y el 15% de las mujeres a nivel mundial (2). Presenta un origen multifactorial, asociado a secreción anormal de insulina, aumento de la resistencia periférica a la insulina, además de hiperandrogenismo y obesidad (2).…”